LUMRYZ™ (sodium oxybate) extended-release for oral suspension received approval by FDA on May 1, 2023.
You are about to enter a site that is for US healthcare professionals only. By selecting "Yes" below, you certify that you are a healthcare professional and that you wish to proceed to the healthcare professionals only site.